Cargando…

GLP-2 cures the gut – What about the liver?

Detalles Bibliográficos
Autor principal:	Pakarinen, Mikko P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710903/ https://www.ncbi.nlm.nih.gov/pubmed/31303504 http://dx.doi.org/10.1016/j.ebiom.2019.07.017

Ejemplares similares

An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes
por: Rosario, Wilfredo, et al.
Publicado: (2015)

What Is Artificial about Life?
por: Giuliani, Alessandro, et al.
Publicado: (2011)

Advice for Junior Faculty Regarding Academic Promotion: What Not to Worry About, and What to Worry About
por: Mbuagbaw, Lawrence, et al.
Publicado: (2020)

Could the menagerie of the gut microbiome really cure cancer? Hope or hype
por: Abid, Muhammad Bilal
Publicado: (2019)

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
por: Liu, Yangyang, et al.
Publicado: (2020)

IMPassionate about immunotherapy for TNBC: from change, to revolution and to cure?
por: Vagia, Elena, et al.
Publicado: (2020)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
por: Soriano, Vicente, et al.
Publicado: (2017)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Simulation-based education: what’s it all about?
por: Cleland, Jennifer
Publicado: (2017)

Chemo cured the cancer: what about the patient?
por: Tunariu, Nina
Publicado: (2015)

What to do about . . . authorship?
por: Macfarlane, Gary J
Publicado: (2021)

Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
por: Østergaard, Jakob A., et al.
Publicado: (2022)

GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata
por: Goggins, Michael
Publicado: (2012)

Is endogenous GLP-1 a major influence on the orbitofrontal cortex?
por: May, Aaron A., et al.
Publicado: (2015)

Skeletal muscle mass and mortality - but what about functional outcome?
por: Puthucheary, Zudin A, et al.
Publicado: (2014)

What can ecological studies tell us about death?
por: Neumark, Yehuda
Publicado: (2017)

What Can Urine Tell Us About Medication Adherence?
por: Anderson, Peter L.
Publicado: (2018)

What was right about Kerala’s response to the COVID-19 pandemic?
por: Menon, Jaideep C, et al.
Publicado: (2020)

What a paediatrician should know about congenital clubfoot
por: Dibello, Daniela, et al.
Publicado: (2020)

What Should Gastroenterologists and Patients Know About COVID-19?
por: Ungaro, Ryan C., et al.
Publicado: (2020)

What COVID-19 may teach us about interdisciplinarity
por: Mol, Annemarie, et al.
Publicado: (2020)

Making pharmaceutical companies report what matters about innovation
por: Cohen, Adam, et al.
Publicado: (2021)

Melanoma overdiagnosis: why it matters and what can be done about it
por: Bell, Katy J.L., et al.
Publicado: (2022)

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
por: Giugliano, Dario, et al.
Publicado: (2021)

Major depressive disorder and the gut microbiome: what is the link?
por: Modesto Lowe, Vania, et al.
Publicado: (2023)

Medical Air: What you don’t know won’t hurt you, but what about your patients?
por: Edwards, Paul, et al.
Publicado: (2018)

What should global mental health do about violent extremism?
por: Weine, S., et al.
Publicado: (2019)

CYP17 and breast cancer: no overall effect, but what about interactions?
por: Little, Julian, et al.
Publicado: (2005)

Acquired resistance to monepantel in C. elegans: What about parasitic nematodes?
por: Fru, Michael Forbiteh, et al.
Publicado: (2014)

Who knew? The misleading specificity of “double-blind” and what to do about it
por: Lang, Thomas A., et al.
Publicado: (2020)

Is Endogenous GLP-1 the Only Important Enhancer of Glucose-Induced Insulin Secretion in Type 2 Diabetes?
por: Deacon, Carolyn F.
Publicado: (2012)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
por: Abdalqadir, Nyan, et al.
Publicado: (2022)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

Maintenance of physical activity: Do we know what we are talking about?
por: Kahlert, Daniela
Publicado: (2015)

What Israeli policy can teach us about elective sex selection
por: Leiter, Gila
Publicado: (2014)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

What every intensivist should know about handovers in the intensive care unit
por: D'Empaire, Pablo Perez, et al.
Publicado: (2017)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

What Can COVID-19 Teach Us about Using AI in Pandemics?
por: Laudanski, Krzysztof, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jb229249o4vccutqn4b7p9magv